Clinical Trials

NCT04389632 | RECRUITING | PHASE1
1006 participants

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2020-06-08
Completion:
2027-06-16
Conditions
  • Carcinoma, Non-Small Cell Lung
  • Squamous Cell Carcinoma of Head and Neck
  • HER2 Negative Breast Neoplasms
  • Esophageal Squamous Cell Carcinoma
  • Esophageal Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Ovarian Neoplasms
  • Cutaneous Squamous Cell Cancer
  • Exocrine Pancreatic Adenocarcinoma
  • Urinary Bladder Neoplasms
  • Uterine Cervical Neoplasms
  • Stomach Neoplasms
Interventions
  • DRUG
No Results Yet
NCT04385082 | ACTIVE_NOT_RECRUITING | PHASE1
160 participants

Cannabis Effects as a Function of Sex

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2021-07-08
Completion:
2026-09-01
Conditions
  • Pain
  • Abuse, Drug
Interventions
  • DRUG
No Results Yet
NCT04297592 | ENROLLING_BY_INVITATION | PHASE4
4618 participants

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2020-06-11
Completion:
2027-01-31
Conditions
  • Infections Joint Prosthetic
  • Overweight or Obesity
  • MSSA Colonization
  • MRSA
  • Chronic Kidney Diseases
  • Diabetes
  • Autoimmune Diseases
  • Inflammatory Disease
  • Tobacco Use
Interventions
  • DRUG
No Results Yet
NCT04106856 | COMPLETED | PHASE1
22 participants

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2019-08-08
Completion:
2024-12-06
Conditions
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Locally Advanced Unresectable Pancreatic Adenocarcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage IIA Pancreatic Cancer AJCC v8
  • Stage IIB Pancreatic Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
Interventions
  • RADIATION
  • DRUG
No Results Yet
NCT03874052 | RECRUITING | PHASE1
51 participants

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2019-08-16
Completion:
2027-12-31
Conditions
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Secondary Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Secondary Acute Myeloid Leukemia
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page